Sector: MedicalMetabasis Therapeutics, Inc (NASDAQ: MBRX)
Headlines
- Trading Outlook for Metabasis Therapeutics Issued by StockPreacher.com
Oct 29, 2009 06:52 AM | BIIB, GENZ, MBRX, TEVA
- Metabasis Announces Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Oct 27, 2009 07:30 AM | LGND, MBRX
- Burnham Institute for Medical Research Appoints First Chief Business Officer
Oct 20, 2009 01:27 PM | MBRX
- 15 Breakout Stocks On Huge Volume
Oct 08, 2009 09:51 AM | BRCD, CGR, ENZN, GIII, ICTG, MBRX
- Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer
Sep 10, 2009 03:37 PM | MBRX, PFE
- Metabasis Hires Financial Advisor to Evaluate Strategic Alternatives
Sep 03, 2009 08:01 AM | MBRX
- Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis' President, CEO & CSO
Sep 01, 2009 08:00 AM | MBRX, MRK
- Earnings Review: March 30, 2009
Mar 30, 2009 07:35 PM | MBRX, OXM, TORM
- Analyst Comments: AtheroGenics, Toyota, Jamba, GlaxoSmithKline, Metabasis, AFLAC, Crown Castle, Epicor, Amylin Pharma, CNOOC, Skyworks, Tejon
Oct 02, 2008 08:33 AM | AFL, AGIX, AMLN, BBI, CAS, CCI
- Analyst Comments: Alexza Pharma, Abbott Lab, Metabasis, Quicksilver, ASM International
Jun 13, 2008 04:45 PM | ABT, ALXA, AMAT, ASMI, KWK, MBRX
- Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Oct 27, 2009 07:53 AM | LGND, MBRX, PFE, SGP
- Metabasis Therapeutics Receives Notice of Noncompliance With Nasdaq Listing Requirements
Sep 18, 2009 05:09 PM | MBRX
- Metabasis Therapeutics Receives Notice of Delisting From Nasdaq Capital Market
Sep 09, 2009 05:13 PM | MBRX
- Metabasis Therapeutics Announces Second Quarter 2009 Financial Results
Aug 06, 2009 04:56 PM | MBRX
- Metabasis Announces Conference Call and Live Webcast to Discuss Second Quarter 2009 Financial Results
Jul 29, 2009 04:34 PM | MBRX
- Metabasis Therapeutics Receives a Development Event Payment from Roche and Notification That Roche Plans to Advance MB11362 into Development for the Treatment of Hepatitis C
Jun 05, 2009 04:31 PM | MBRX
- Metabasis Therapeutics Announces Corporate Restructuring and Notice of Noncompliance With Nasdaq Listing Requirements
May 27, 2009 03:58 AM | MBRX
- Metabasis Therapeutics Announces First Quarter 2009 Financial Results
May 14, 2009 04:31 PM | MBRX
- Metabasis Announces Conference Call and Live Webcast to Discuss First Quarter 2009 Financial Results
May 08, 2009 02:11 PM | MBRX
- Metabasis Therapeutics Announces Late-Breaking Abstract on MB07803 Trial Results Accepted for Presentation at the American Diabetes Association Meeting
May 06, 2009 08:16 AM | MBRX
- Form 4 Laikind Paul K For: Jun 23 (10K)
Jun 25, 2009 01:16 PM
- Form 4 HALE DAVID F For: Jun 23 (10K)
Jun 25, 2009 01:06 PM
- Form 4 Schreiner George For: Jun 23 (10K)
Jun 24, 2009 11:13 PM
- Form 4 ROHN WILLIAM R For: Jun 23 (10K)
Jun 24, 2009 11:13 PM
- Form 4 METABASIS THERAPEUTICS For: Jun 23 Filed by: ORONSKY ARNOLD L (10K)
Jun 24, 2009 10:55 PM
- Form 4 BURGESS DANIEL D For: Jun 23 (10K)
Jun 24, 2009 10:52 PM
- Form 4 Nguyen Tran For: Mar 02 (10K)
Mar 02, 2009 06:28 PM
- Form 3 Nguyen Tran For: Mar 02 (10K)
Mar 02, 2009 06:28 PM
- Form 4 METABASIS THERAPEUTICS For: Jan 29 Filed by: Erion Mark D (10K)
Feb 02, 2009 06:47 PM
- Form 4 METABASIS THERAPEUTICS For: Jan 29 Filed by: Millican Trisha (10K)
Feb 02, 2009 06:45 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MBRX
|
Compare to S&P
|
| YTD |
31.25 %
|
8.42 %
|
| 4 Weeks |
-23.64 %
|
-24.04 %
|
| 12 Weeks |
-10.64 %
|
-16.14 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 139.13 %
|
|
EPS Growth in Last Year: 126.47 %
|
|
Sales Growth in Last Quarter: -49.75 %
|
|
Sales Growth in Last Quarter: 248.07 %
|
|
